Related references
Note: Only part of the references are listed.Recent advances in the IL-17 cytokine family
Sarah L. Gaffen
CURRENT OPINION IN IMMUNOLOGY (2011)
Intravesical Interleukin-15 Gene Therapy in an Orthotopic Bladder Cancer Model
Kazuhiro Matsumoto et al.
HUMAN GENE THERAPY (2011)
A disproportion of T(H)1/T(H)2 cytokines with predominance of T(H)2, in urothelial carcinoma of bladder
Abhigyan Satyam et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2011)
Crossing paths: interactions between the cell death machinery and growth factor survival signals
Gabriela Brumatti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
IL-20: Biological functions mediated through two types of receptor complexes
Ursula Maria Wegenka
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer
Wun-Jae Kim et al.
MOLECULAR CANCER (2010)
Strategies for molecular expression profiling in bladder cancer
Anirban P. Mitra et al.
CANCER AND METASTASIS REVIEWS (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
IL-20 Is Regulated by Hypoxia-Inducible Factor and Up-Regulated after Experimental Ischemic Stroke
Wei-Yu Chen et al.
JOURNAL OF IMMUNOLOGY (2009)
Interferon-λs: the modulators of antivirus, antitumor, and immune responses
Mingcai Li et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization
Cecilia Garlanda et al.
TRENDS IN IMMUNOLOGY (2009)
Inflammation: its role and interplay in the development of cancer, with special focus on gynecological malignancies
B. Goswami et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2008)
Intravesical treatments of bladder cancer: Review
Zancong Shen et al.
PHARMACEUTICAL RESEARCH (2008)
Bladder cancer angiogenesis and metastasis-translation from murine model to clinical trial
Peter C. Black et al.
CANCER AND METASTASIS REVIEWS (2007)
IL-28 elicits antitumor responses against murine fibrosarcoma
Muneo Numasaki et al.
JOURNAL OF IMMUNOLOGY (2007)
Novel interferon-λs induce antiproliferative effects in neuroendocrine tumor cells
Kathrin Zitzmann et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Characterization of the mouse IFN-λ ligand-receptor system:: IFN-λs exhibit antitumor activity against B16 melanoma
A Lasfar et al.
CANCER RESEARCH (2006)
Interleukin-20 promotes angiogenesis in a direct and indirect manner
MY Hsieh et al.
GENES AND IMMUNITY (2006)
Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1 beta and tumor necrosis factor-alpha
K Bouchelouche et al.
UROLOGY (2006)
YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis
C. N. Rathcke et al.
INFLAMMATION RESEARCH (2006)
IL-28A and IL-29 mediate antiproliferative and antiviral signals in intestinal epithelial cells and murine CMV infection increases colonic IL-28A expression
S Brand et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2005)
Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication
Haizhen Zhu et al.
VIROLOGY JOURNAL (2005)
ERK1/2 mediates TNF-α-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-κB and AP-1:: Involvement of the ras dependent pathway
SK Moon et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
A random variance model for detection of differential gene expression in small microarray experiments
GW Wright et al.
BIOINFORMATICS (2003)
Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
A Böhle et al.
JOURNAL OF UROLOGY (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma
S Gerhards et al.
UROLOGY (2001)
Interleukin 20: Discovery, receptor identification, and role in epidermal function
H Blumberg et al.
CELL (2001)